160 related articles for article (PubMed ID: 9351397)
1. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice.
Reaven P; Merat S; Casanada F; Sutphin M; Palinski W
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2250-6. PubMed ID: 9351397
[TBL] [Abstract][Full Text] [Related]
2. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.
Keren P; George J; Shaish A; Levkovitz H; Janakovic Z; Afek A; Goldberg I; Kopolovic J; Keren G; Harats D
Diabetes; 2000 Jun; 49(6):1064-9. PubMed ID: 10866061
[TBL] [Abstract][Full Text] [Related]
3. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.
Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1223-30. PubMed ID: 10323773
[TBL] [Abstract][Full Text] [Related]
4. Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice.
Zhu L; He Z; Wu F; Ding R; Jiang Q; Zhang J; Fan M; Wang X; Eva B; Jan N; Liang C; Wu Z
Cardiovasc Diabetol; 2014 Nov; 13():151. PubMed ID: 25391642
[TBL] [Abstract][Full Text] [Related]
5. Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice.
Lin RY; Choudhury RP; Cai W; Lu M; Fallon JT; Fisher EA; Vlassara H
Atherosclerosis; 2003 Jun; 168(2):213-20. PubMed ID: 12801603
[TBL] [Abstract][Full Text] [Related]
6. Increased atherosclerosis in streptozotocin-induced diabetic mice.
Kunjathoor VV; Wilson DL; LeBoeuf RC
J Clin Invest; 1996 Apr; 97(7):1767-73. PubMed ID: 8601643
[TBL] [Abstract][Full Text] [Related]
7. Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys.
Litwak KN; Cefalu WT; Wagner JD
Metabolism; 1998 Aug; 47(8):947-54. PubMed ID: 9711990
[TBL] [Abstract][Full Text] [Related]
8. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts.
Park L; Raman KG; Lee KJ; Lu Y; Ferran LJ; Chow WS; Stern D; Schmidt AM
Nat Med; 1998 Sep; 4(9):1025-31. PubMed ID: 9734395
[TBL] [Abstract][Full Text] [Related]
9. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis.
Palinski W; Tangirala RK; Miller E; Young SG; Witztum JL
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1569-76. PubMed ID: 7583529
[TBL] [Abstract][Full Text] [Related]
10. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia in normotriglyceridemic, hypercholesterolemic insulin-treated diabetic rabbits does not accelerate atherogenesis.
Nordestgaard BG; Zilversmit DB
Atherosclerosis; 1988 Jul; 72(1):37-47. PubMed ID: 3063265
[TBL] [Abstract][Full Text] [Related]
12. [Advanced glycation end products accelerate atherosclerosis via enhancement of oxidative stress].
Zhang WR; Hou FF; Liu SX; Guo ZJ; Zhou ZM; Wang GB; Fu N; Liu ZQ; Wang L; Zhou M
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1066-72. PubMed ID: 15312503
[TBL] [Abstract][Full Text] [Related]
13. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
[TBL] [Abstract][Full Text] [Related]
14. Omapatrilat, an angiotensin-converting enzyme and neutral endopeptidase inhibitor, attenuates early atherosclerosis in diabetic and in nondiabetic low-density lipoprotein receptor-deficient mice.
Levy Z; Dvir A; Shaish A; Trestman S; Cohen H; Levkovietz H; Rhachmani R; Ravid M; Harats D
Int J Exp Diabesity Res; 2003; 4(1):59-64. PubMed ID: 12745671
[TBL] [Abstract][Full Text] [Related]
15. APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins.
Yamanouchi J; Takatori A; Itagaki S; Kawamura S; Yoshikawa Y
Exp Anim; 2000 Oct; 49(4):267-74. PubMed ID: 11109552
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.
Renard CB; Kramer F; Johansson F; Lamharzi N; Tannock LR; von Herrath MG; Chait A; Bornfeldt KE
J Clin Invest; 2004 Sep; 114(5):659-68. PubMed ID: 15343384
[TBL] [Abstract][Full Text] [Related]
17. Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis.
Merat S; Fruebis J; Sutphin M; Silvestre M; Reaven PD
J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):B85-94. PubMed ID: 10737683
[TBL] [Abstract][Full Text] [Related]
18. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits.
Palinski W; Koschinsky T; Butler SW; Miller E; Vlassara H; Cerami A; Witztum JL
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):571-82. PubMed ID: 7749871
[TBL] [Abstract][Full Text] [Related]
19. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice.
Spencer MW; Mühlfeld AS; Segerer S; Hudkins KL; Kirk E; LeBoeuf RC; Alpers CE
Am J Nephrol; 2004; 24(1):20-31. PubMed ID: 14671436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
